Allspring Global Investments Holdings, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$113,472
+7.9%
105,067
+28.9%
0.00%
Q2 2023$105,187
-9.8%
81,541
-7.7%
0.00%
Q1 2023$116,668
+11.2%
88,385
+26.4%
0.00%
Q4 2022$104,887
+155.8%
69,925
+100.2%
0.00%
Q3 2022$41,000
+127.8%
34,936
+111.5%
0.00%
Q2 2022$18,000
-97.6%
16,515
-93.3%
0.00%
-100.0%
Q1 2022$738,000
-5.3%
247,124
-16.0%
0.00%0.0%
Q4 2021$779,000294,3320.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders